LAZARD ASSET MANAGEMENT LLC – Vertex Pharmaceuticals Incorporated Transaction History
LAZARD ASSET MANAGEMENT LLC portfolio value:
$180.62M
portfolio value
LAZARD ASSET MANAGEMENT LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -27.79% | -240.06K shares | -62.81M | $289.54 | 623.84K |
| Q2 2022 | share | Decrease | -3.78% | -33.93K shares | 9.13M | $281.79 | 863.90K |
| Q1 2022 | share | Decrease | -1.95% | -17.87K shares | 33.21M | $260.97 | 897.84K |
| Q4 2021 | share | Increase | +451.85% | 749.78K shares | 170.99M | $222.45 | 915.72K |
| Q3 2021 | share | Increase | +17.07% | 24.19K shares | 1.52M | $181.39 | 165.93K |
| Q2 2021 | share | Increase | +22.31% | 25.85K shares | 3.67M | $201.63 | 141.74K |
| Q1 2021 | share | Decrease | -12.28% | -16.22K shares | -6.31M | $214.89 | 115.88K |
| Q4 2020 | share | Decrease | -35.93% | -74.07K shares | -24.88M | $236.34 | 132.10K |
| Q3 2020 | share | Increase | +2.98% | 5.95K shares | -2.02M | $272.12 | 206.18K |
| Q2 2020 | share | Increase | +241.54% | 141.6K shares | 44.17M | $290.31 | 200.22K |
| Q1 2020 | share | Increase | +5.90% | 3.26K shares | 1.82M | $237.95 | 58.62K |
| Q4 2019 | share | Increase | +1.89% | 1.02K shares | 2.91M | $218.95 | 55.35K |
| Q3 2019 | share | Decrease | -30.81% | -24.19K shares | -5.19M | $169.42 | 54.33K |
| Q2 2019 | share | Decrease | -8.93% | -7.69K shares | -1.46M | $183.38 | 78.53K |
| Q1 2019 | share | Increase | +160.90% | 53.17K shares | 10.38M | $183.95 | 86.22K |
| Q4 2018 | share | Decrease | -15.23% | -5.93K shares | -2.03M | $165.71 | 33.05K |
| Q3 2018 | share | Increase | +22.85% | 7.25K shares | 2.12M | $192.74 | 38.98K |
| Q2 2018 | share | Decrease | -80.10% | -127.77K shares | -20.60M | $169.96 | 31.73K |
| Q1 2018 | share | Decrease | -8.32% | -14.47K shares | -77K | $162.98 | 159.50K |
| Q4 2017 | share | Increase | +0.33% | 564 shares | -294K | $149.86 | 173.98K |
| Q3 2017 | share | Decrease | -13.79% | -27.74K shares | 443K | $152.04 | 173.42K |
| Q2 2017 | share | Decrease | -55.89% | -254.90K shares | -23.94M | $128.87 | 201.16K |
| Q1 2017 | share | Decrease | -37.13% | -269.33K shares | -3.56M | $109.35 | 456.07K |
| Q4 2016 | share | Decrease | -39.42% | -472.06K shares | -50.98M | $73.67 | 725.40K |
| Q3 2016 | share | Decrease | -5.39% | -68.28K shares | -4.45M | $87.21 | 1.19M |
| Q2 2016 | share | Increase | +28.85% | 283.41K shares | 30.79M | $86.02 | 1.26M |
| Q1 2016 | share | Increase | +25.07% | 196.93K shares | -20.74M | $79.49 | 982.34K |